The evolving pharmacotherapy of pulmonary fibrosis

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.1, 2013-01, pp. : 79-89

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy in patients with idiopathic pulmonary fibrosis

By Nagai S Handa T Kim DS

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 11, 2008-08 ,pp. : 1909-1925

Informa Healthcare

Access to resources Recommend Favorite

Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy

By Thannickal Victor J Flaherty Kevin R Martinez Fernando J Lynch 3rd Joseph P

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 8, 2004-08 ,pp. : 1671-1686

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy of pulmonary embolism

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 12, 2002-12 ,pp. : 1719-1725

Informa Healthcare

Access to resources Recommend Favorite

Pirfenidone: In Idiopathic Pulmonary Fibrosis

By Carter Natalie J.

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1721-1732

Adis International

Access to resources Recommend Favorite

Evaluation of current pharmacotherapy of chronic obstructive pulmonary disease

By Culpitt S.V. Rogers D.F.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 5, 2000-07 ,pp. : 1007-1020

Informa Healthcare

Access to resources Recommend Favorite